Bellevue Group AG

SEC CIK: 0001674546
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 157,291
Value: $98.1M
% of portfolio: 2.1%
Quarters held: 22; Since Q1 2021

Holdings of REGN by Bellevue Group AG, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	157,291	$98.1M	2.1%	−121,383−43.6%	Reduced	Holders
Q1 2026	278,674	$215.3M	5.1%	+264,746+1,900.8%	Added	Holders
Q4 2025	13,928	$10.8M	0.2%	−1,129−7.5%	Reduced	Holders
Q3 2025	15,057	$8.47M	0.2%	−11,687−43.7%	Reduced	Holders
Q2 2025	26,744	$14.0M	0.3%	−1,779−6.2%	Reduced	Holders
Q1 2025	28,523	$18.1M	0.4%	−2,889−9.2%	Reduced	Holders
Q4 2024	31,412	$22.4M	0.4%	+4,636+17.3%	Added	Holders
Q3 2024	26,776	$28.1M	0.5%	−5,521−17.1%	Reduced	Holders
Q2 2024	32,297	$33.9M	0.6%	+25,220+356.4%	Added	Holders
Q1 2024	7,077	$6.81M	0.1%	−3,632−33.9%	Reduced	Holders
Q4 2023	10,709	$9.41M	0.1%	−4,230−28.3%	Reduced	Holders
Q3 2023	14,939	$12.3M	0.2%	−1,388−8.5%	Reduced	Holders
Q2 2023	16,327	$11.7M	0.2%	+1,011+6.6%	Added	Holders
Q1 2023	15,316	$12.6M	0.2%	−362−2.3%	Reduced	Holders
Q4 2022	15,678	$11.3M	0.2%	−1,711−9.8%	Reduced	Holders
Q3 2022	17,389	$12.0M	0.2%	−338−1.9%	Reduced	Holders
Q2 2022	17,727	$10.5M	0.1%	−72,553−80.4%	Reduced	Holders
Q1 2022	90,280	$63.1M	0.7%	−2,780−3.0%	Reduced	Holders
Q4 2021	93,060	$58.8M	0.6%	−13,350−12.5%	Reduced	Holders
Q3 2021	106,410	$64.4M	0.7%	+750+0.7%	Added	Holders
Q2 2021	105,660	$59.0M	0.6%	+69,860+195.1%	Added	Holders
Q1 2021	35,800	$16.9M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.